Nicht aus der Schweiz? Besuchen Sie lehmanns.de
Neurodegenerative Diseases -

Neurodegenerative Diseases

Translational Models, Mechanisms, and Therapeutics
Buch | Hardcover
236 Seiten
2024
CRC Press (Verlag)
978-1-032-61324-6 (ISBN)
CHF 209,45 inkl. MwSt
  • Lieferbar (Termin unbekannt)
  • Versandkostenfrei
  • Auch auf Rechnung
  • Artikel merken
This reference book provides a comprehensive overview of models and therapeutic approaches against neurodegenerative diseases, including Parkinson’s disease, Alzheimer’s disease, Huntington’s disease, and Amyotrophic lateral sclerosis.
This reference book provides a comprehensive overview of models and therapeutic approaches against neurodegenerative diseases, including Parkinson’s disease, Alzheimer’s disease, Huntington’s disease, and amyotrophic lateral sclerosis. It explores models based on the chemical, induced, cellular, genetic, transgenic, and 3D organoid approaches in neurodegenerative diseases. The book also reviews advantages and limitations of these models in designing the treatment strategies. Additionally, the book covers the emerging field of bioinformatics and its application in modeling various neurodegenerative diseases. Towards the end, the book highlights the role of holistic management, precision medicine, OMICS, and gene therapy against neurodegenerative disorders. It examines the implications and significance of stem cells therapy in translational models of neurodegenerative diseases. This book is an invaluable resource for researchers, neuroscientists, and neurosurgeons for getting in-depth information on the neurodegenerative models and therapeutic approaches.

Key Features:



Provides a comprehensive overview of neurodegenerative diseases and their models
Examines the limitations associated with modeling neurodegenerative diseases
Presents novel treatment strategies for Alzheimer's disease using cellular models
Reviews importance of 3D organoid models for therapeutic approaches in Parkinson's disease
Covers modeling techniques in understanding prion diseases
Explores the role of genetic models in understanding Huntington's disease

Dr. Sachchida Nand Rai is a Research Associate (ICMR-RA) at Centre of Experimental Medicine and Surgery, Institute of Medical Sciences, Banaras Hindu University (BHU), Varanasi since 27th Jan 2023. Dr. Rai also completed his Ph.D from the Biochemistry Department (Institute of Science) from BHU. Before joining the BHU as Research Associate, he was post-Doctoral fellow at Centre of Biotechnology, University of Allahabad, Prayagraj, India. He has published several research articles in high impact journals and has published 3 books. Dr. Rai serves as editorial board member in many reputed journals. He is investigating the neuroprotective activity of common Indian medicinal plants in toxin induced Parkinsonian mouse model. He is also member of the Indian Academy of Neurosciences, (India). Dr. Sandeep Singh is a Post-Doctoral Fellow at Cellular Neurobiology Laboratory, Salk Institute for Biological Studies, San Diego, California, USA. Before joining the Salk Institute, he was post-Doctoral fellow at Hadassah Biological Psychiatry Laboratory, Hadassah - Hebrew University Medical Center, Jerusalem, Israel. During PhD, he has presented his work in many world-renowned international neuroscience conferences such as Society for Neuroscience (USA), International Society for Neurochemistry (Paris), Japan Neuroscience Society (Japan). He was a recipient of IBRO-APRC Exchange Fellowship (2019) to work at National Institute of Advanced Industrial Science & Technology (AIST), Japan and Senior Research fellowship (2018) from Indian Council of Medical Research, India. He has published several research articles in journals of high repute. He is investigating the potential role of natural compounds and how they modulate the different molecular pathways during aging and age associated diseases. He is also member of the Indian Science Congress Association (India), Indian Academy of Neurosciences, (India). Dr. Santosh Kumar Singh is a Senior Scientist at Centre of Experimental Medicine and Surgery (CEMS), Faculty of Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi-221005, India. He has completed his Ph.D. from the Botany Department (Institute of Science), BHU in 1998. He was a Visiting Scientist at Department of Photosynthesis, Institute of Physical Biology, University of South Bohemia, Czech Republic, in 2003. He has published more than 75 research articles in high impact factor journal and has published several books. Drug Discovery & Development, Microbial Biotechnology and Nanobiotechnology are some of his major areas of research. He is also Life time member of Mycological society of India, Life time member of Society of Biological Chemists, India, Member of the Society for Ethnopharmacology, Kolkata, India (SFE-INDIA). He was also participated as resource person in Karyashala Training Course Under Accelerate Vigyan Scheme, SERB, DST. He was awarded with “National Award for “Outstanding Efforts in Science and Technology Communication through Innovative and Traditional methods (2021)” conferred by Department of Science and Technology, Ministry of Science and Technology, Government of India. He was also received the order of academic excellence in publication (2020-2021), Institute of Medical Sciences, Banaras Hindu University, Varanasi.

1: General Introduction to Different Neurodegenerative Diseases.

2: Chemical-Induced Parkinson’s disease model and associated therapeutic strategies.

3: Recent advancement in the treatment of Parkinson’s disease cellular models.

4: Relevance of genetic model and linked therapeutics in Parkinson’s disease.

5: Importance of Newer 3D Organoids model based therapeutic approach in Parkinson’s disease.

6: Chemical Induced Alzheimer’s disease model and their therapeutic significance along with limitations.

7: Advancement in the Genetic Model of Alzheimer’s disease.

8: Organoids and Alzheimer's disease.

9: Importance of Genetic Model in Huntington’s disease.

10: Natural source of drugs for neurodegenerative diseases.

11: Limitations of modelling in different neurodegenerative diseases.

12: Significance of 3D Organoid Model in Neurodegenerative Diseases.

13: Recent advancement in therapeutics of rare neurological disorders.

14: Bio-informatics based modeling in different neurodegenerative diseases and associated therapeutic strategies.

15: Holistic Management of Diverse Neurodegenerative Diseases in Different Translational Models.

16: Gene Therapy, OMICS Approaches, and Translational Neurodegenerative Models: Recent Advancements and Future Perspectives.

17: Implication and importance of Stem cell therapy in a translational model of neurodegenerative diseases.

Erscheinungsdatum
Zusatzinfo 13 Tables, black and white; 28 Line drawings, color; 4 Line drawings, black and white; 5 Halftones, color; 33 Illustrations, color; 4 Illustrations, black and white
Verlagsort London
Sprache englisch
Maße 178 x 254 mm
Themenwelt Medizin / Pharmazie Medizinische Fachgebiete Neurologie
Medizin / Pharmazie Medizinische Fachgebiete Pharmakologie / Pharmakotherapie
Naturwissenschaften Biologie Humanbiologie
Naturwissenschaften Biologie Zoologie
Technik
ISBN-10 1-032-61324-6 / 1032613246
ISBN-13 978-1-032-61324-6 / 9781032613246
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich
interdisziplinäre Diagnose- und Behandlungsstrategien

von Christoph Maier; Ulrike Bingel; Esther Pogatzki-Zahn

Buch | Hardcover (2024)
Urban & Fischer in Elsevier (Verlag)
CHF 135,75